A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients

NCT00463697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: GW642444H (100mcg)
DRUG: placebo
DRUG: GW642444M (25, 100 & 400 mcg)

Sponsor

GlaxoSmithKline